ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TELA TELA Bio Inc

5.70
-0.02 (-0.35%)
Last Updated: 13:15:03
Delayed by 15 minutes

Period:

Draw Mode:

Volume 27,938
Bid Price 5.70
Ask Price 5.74
News -
Day High 5.7537

Low
4.2349

52 Week Range

High
11.26

Day Low 5.5928
Share Name Share Symbol Market Stock Type
TELA Bio Inc TELA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -0.35% 5.70 13:15:03
Open Price Low Price High Price Close Price Previous Close
5.5928 5.5928 5.7537 5.72
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
694 27,938 US$ 5.68 US$ 158,758 - 4.2349 - 11.26
Last Trade Type Quantity Price Currency
13:15:02 5 US$ 5.72 USD

TELA Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
138.36M 24.49M - 58.45M -46.66M -1.91 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

TELA Bio News

Date Time Source News Article
6/06/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
6/06/202415:15Edgar (US Regulatory)Form 8-K - Current report
6/04/202415:05GlobeNewswire Inc.TELA Bio Appoints Jeffrey Blizard to its Board of Directors
5/20/202415:15Edgar (US Regulatory)Form 8-K - Current report
5/20/202415:03GlobeNewswire Inc.TELA Bio Appoints Greg Firestone as Chief Commercial Officer
5/10/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/10/202415:05GlobeNewswire Inc.TELA Bio Announces Inducement Grants Under Nasdaq Listing..
5/09/202415:20Edgar (US Regulatory)Form 8-K - Current report
5/09/202415:05GlobeNewswire Inc.TELA Bio Reports First Quarter 2024 Financial Results
4/25/202406:00GlobeNewswire Inc.TELA Bio to Announce First Quarter 2024 Financial Results
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TELA Message Board. Create One! See More Posts on TELA Message Board See More Message Board Posts

Historical TELA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.706.005.395.63142,1600.000.00%
1 Month5.436.505.395.83116,3800.274.97%
3 Months5.376.504.305.18168,5180.336.15%
6 Months5.577.844.305.79138,8550.132.33%
1 Year11.0411.264.23496.83140,003-5.34-48.37%
3 Years13.1116.52684.23498.1378,210-7.41-56.52%
5 Years13.7523.5454.23499.5068,451-8.05-58.55%

TELA Bio Description

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.

Your Recent History

Delayed Upgrade Clock